Paul L. Berns - 17 Feb 2026 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Reporting relationship: Title: Chief Executive Officer and Chairman of the Board, Director
Issuer ticker: NMRA
Reported as of: 17 Feb 2026
Net transaction value: -$34,459
SEC form: 4
Accepted by SEC: 19 Feb 2026, 17:05:16 UTC
Prior SEC filing: 09 Jan 2026
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Milligan, as Attorney-in-Fact for Paul L. Berns

Key filing fact

Paul L. Berns filed Form 4 for Neumora Therapeutics, Inc. (NMRA) on 19 Feb 2026.

Key facts

This page summarizes Paul L. Berns's Form 4 filing for Neumora Therapeutics, Inc. (NMRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Feb 2026, 17:05.

Change

Previous filing in this sequence was filed on 09 Jan 2026.
Current net transaction value: -$34,459.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001202769 Primary reporting owner

BERNS PAUL L

Relationship: Title: Chief Executive Officer and Chairman of the Board, Director
Address: C/O NEUMORA THERAPEUTICS, INC., 260 ARSENAL WAY, SUITE 1, WATERTOWN
Signature: /s/ Michael Milligan, as Attorney-in-Fact for Paul L. Berns
Signature date: 19 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NMRA transaction

Common Stock

Sale

Transaction value: $34,459
Shares: -9,819
Change %: -0.13%
Price: $3.51
Shares after: 7,395,185
Date: 17 Feb 2026
Ownership: Direct
Footnotes: F1, F2

NMRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 133,097
Date: 17 Feb 2026
Ownership: See footnote
Footnotes: F3

NMRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 133,097
Date: 17 Feb 2026
Ownership: See footnote
Footnotes: F4

NMRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 133,097
Date: 17 Feb 2026
Ownership: See footnote
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Footnote F2

This transaction was executed in multiple trades in prices ranging from $3.48 to $3.545, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F3

Held by LULU TRUST OF 2024 FBO AB.

Footnote F4

Held by LULU TRUST OF 2024 FBO OB.

Footnote F5

Held by LULU TRUST OF 2024 FBO HB.

SEC remarks

Title: Chief Executive Officer and Chairman of the Board